CVS 2016 profit forecast hurt by healthcare plans, Target deal

Go back to CVS 2016 profit forecast hurt by healthcare plans, Target deal

Margin Pressures Could Weigh on CVS Health (CVS) Shares; Oppenheimer Cuts Price Target to $115

November 2, 2015 11:16 AM EST

Oppenheimer maintained an Outperform rating on CVS Health (NYSE: CVS), and cut the price target to $115.00 (from $122.00), following the company's 3Q earnings results. CVS reported 3Q revenue of $38.6B vs. consensus $37.9B. Adj. EPS was $1.29, in line with consensus $1.29. Analyst Mohan Naidu believes that the margin outlook and lack of clarity on organic growth in... More

Leerink Partners Would Buy CVS Health (CVS) on Current Weakness

October 30, 2015 1:39 PM EDT

Leerink Partners reiterated an Outperform rating and $125.00 price target on CVS Health (NYSE: CVS) following the company's 3Q earnings and conference call. Management highlighted that the core business continues to grow at a healthy rate. While 2016E EPS guidance is below consensus expectations, management reiterated that their longterm adjusted EPS growth... More

Target (TGT) Announces Holiday Shopping Plans; Includes New, Enhanced Digital Tools

October 30, 2015 11:52 AM EDT

Target (NYSE: TGT) announced it will give guests a more convenient shopping experience this holiday season through new and expanded digital tools and resources, including free shipping and returns at Target.com, and new international shipping options. Targets holiday shoppers also will find top gifts and décor, ways to save throughout the season, and a marketing campaign, The Holiday Odyssey, that will tell the tale of a larger-than-life holiday journey.

Target is starting the season with momentum in our business, anchored by increased store traffic and strength in our signature... More